Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Income from Continuing Operations (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Income from Continuing Operations for 8 consecutive years, with 12933000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 154.47% to 12933000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 49331000.0 through Dec 2025, down 132.9% year-over-year, with the annual reading at 49331000.0 for FY2025, 132.9% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 12933000.0 at Precision Biosciences, up from 20002000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 25429000.0 in Q2 2024, with the low at 30714000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 11470200.0, with a median of 13775500.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations soared 1564.8% in 2024, then tumbled 582.47% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 30714000.0 in 2021, then surged by 65.3% to 10658000.0 in 2022, then decreased by 28.0% to 13642000.0 in 2023, then crashed by 74.05% to 23744000.0 in 2024, then surged by 154.47% to 12933000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 12933000.0, 20002000.0, and 21119000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.